Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sattva S. Neelapu, MD"'
Autor:
Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ahmed Fetooh, MBBS, Gohar S. Manzar, MD, PhD, Kelsey L. Corrigan, MD, MPH, Benjamin R. Schrank, MD, PhD, Lewis Nasr, MD, MS, Dai Chihara, MD, PhD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Preetesh Jain, MBBS, MD, DM, PhD, Sattva S. Neelapu, MD, Paolo Strati, MD, Loretta J. Nastoupil, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD, PhD, Jillian R. Gunther, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 12, Pp 101648- (2024)
Purpose: Definitive intent radiation therapy (RT) for early-stage mucosa-associated lymphoid tissue (MALT) lymphoma typically includes a dose of 24 to 30 Gy. While modest, these doses may have associated toxicity. For patients with indolent B-cell ly
Externí odkaz:
https://doaj.org/article/8e49e699e2d345d8915aa234f82ed81f
Autor:
Tommy Sheu, MD, Sarah A. Milgrom, MD, Therese Y. Andraos, MD, Jillian R. Gunther, MD, PhD, Linda Chi, MD, Loretta Nastoupil, MD, Nathan Fowler, MD, Yasuhiro Oki, MD, Michelle A. Fanale, MD, Luis E. Fayad, MD, Fredrick Hagemeister, MD, Sattva S. Neelapu, MD, L. Jeffrey Medeiros, MD, Chitra Hosing, MD, Yago Nieto, MD, PhD, Sairah Ahmed, MD, Amin M. Alousi, MD, Bouthaina Dabaja, MD, Chelsea C. Pinnix, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 4, Pp 639-646 (2018)
Background: For patients with primary diffuse large B-cell lymphoma of the central nervous system (PCNSL), whole-brain radiation therapy (WBRT) to doses of ≥45 Gy are often given after a partial response (PR) to methotrexate-based induction chemoth
Externí odkaz:
https://doaj.org/article/1f02995f8438432da5c4519e8317b653